Volume 35, Issue 10 pp. 5527-5563
REVIEW

A comprehensive review of the therapeutic potential of curcumin nanoformulations

Khadijeh Khezri

Corresponding Author

Khadijeh Khezri

Deputy of Food and Drug Administration, Urmia University of Medical Sciences, Urmia, Iran

Correspondence

Khadijeh Khezri, Deputy of Food and Drug Administration, Urmia University of Medical Sciences, Urmia, Iran.

Email: [email protected]

Majid Saeedi, Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Email: [email protected]

Search for more papers by this author
Majid Saeedi

Corresponding Author

Majid Saeedi

Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran

Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

Correspondence

Khadijeh Khezri, Deputy of Food and Drug Administration, Urmia University of Medical Sciences, Urmia, Iran.

Email: [email protected]

Majid Saeedi, Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Email: [email protected]

Search for more papers by this author
Hassan Mohammadamini

Hassan Mohammadamini

Khoy University of Medical Sciences, Khoy, Iran

Search for more papers by this author
Abbas Seyed Zakaryaei

Abbas Seyed Zakaryaei

Urmia University of Medical Sciences, Urmia, Iran

Search for more papers by this author
First published: 15 June 2021
Citations: 16

Abstract

Today, due to the prevalence of various diseases such as the novel coronavirus (SARS-CoV-2), diabetes, central nervous system diseases, cancer, cardiovascular disorders, and so on, extensive studies have been conducted on therapeutic properties of natural and synthetic agents. A literature review on herbal medicine and commercial products in the global market showed that curcumin (Cur) has many therapeutic benefits compared to other natural ingredients. Despite the unique properties of Cur, its use in clinical trials is very limited. The poor biopharmaceutical properties of Cur such as short half-life in plasma, low bioavailability, poor absorption, rapid metabolism, very low solubility (at acidic and physiological pH), and the chemical instability in body fluids are major concerns associated with the clinical applications of Cur. Recently, nanoformulations are emerging as approaches to develop and improve the therapeutic efficacy of various drugs. Many studies have shown that Cur nanoformulations have tremendous therapeutic potential against various diseases such as SARS-CoV-2, cancer, inflammatory, osteoporosis, and so on. These nanoformulations can inhibit many diseases through several cellular and molecular mechanisms. However, successful long-term clinical results are required to confirm their safety and clinical efficacy. The present review aims to update and explain the therapeutic potential of Cur nanoformulations.

CONFLICT OF INTEREST

Authors declare that there is no conflict of interest in this study.

DATA AVAILABILITY STATEMENT

The data for this study can be requested from the corresponding author via email.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.